Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis

OBJECTIVE: The objective of this study was to compare the efficacy and safety of two rituximab (RTX) regimens for the induction of remission in severe antineutrophil cytoplasm antibody–associated vasculitis (AAV): the four‐dose (375 mg/m(2) intravenously weekly) versus the two‐dose (1000 mg intraven...

Descripción completa

Detalles Bibliográficos
Autores principales: Bénard, Valérie, Farhat, Cynthia, Zarandi‐Nowroozi, Melissa, Durand, Madeleine, Charles, Pierre, Puéchal, Xavier, Guillevin, Loic, Pagnoux, Christian, Makhzoum, Jean‐Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280814/
https://www.ncbi.nlm.nih.gov/pubmed/34114739
http://dx.doi.org/10.1002/acr2.11274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280814/
https://www.ncbi.nlm.nih.gov/pubmed/34114739
http://dx.doi.org/10.1002/acr2.11274

Ejemplares similares